This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Determine whether a 6-month or 12-month fund is right for you by assessing income stability, essential expenses, and personal risk appetite.
15,911 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
asml stock popped today as investors chased AI-driven demand for semiconductor equipment. This guide breaks down what...
Oil’s surge fuels a wave of gains in key energy ETFs, led by XLE, OIH, and PBT, as supply, demand, and drilling budge...
Investors are hoarding cash as volatility climbs and policy signals shift risk expectations. The dash cash only just ...
Meta is plowing ahead with AI investments. This article explains why the reason meta's spending spree could stay on t...
Titan America (TTAM) is shaping investor expectations in 2026 as Q1 results roll in. This deep dive translates earnin...
The Trek CEO’s daily routine fuses a lifelong love of reading with a belief that business should serve society, not j...
Vericel faces a pivotal 2026 earnings season. This guide breaks down the drivers behind the numbers, what to watch in...
As of May 2026, the U.S. tech economy hinges on institutional design that turns ideas into markets. This piece explai...
Archer’s Q1 2026 numbers set the tone for the year. This article breaks down the earnings call, explains what really ...
The Department of Homeland Security is requesting $7.5 million to develop wearable facial-recognition glasses for ICE...
A JPMorgan client note argues that Strategy may purchase as much as $30 billion of Bitcoin in 2026, placing Bitcoin i...